Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Germany

Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Under Review
Cabotegravir (CAB) for PrEP — ViiV
Approved 2023 2023
Dapivirine Vaginal Ring (DVR) — Pop Council
Not Approved
Oral PrEP TDF/FTC — Gilead (Truvada)
Approved 2016 2016
Oral PrEP TDF/xTC* - generic
Approved
Oral PrEP F/TAF — Gilead
Not Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

N/A Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Policy Frameworks

Integrated Strategy for HIV, Hepatitis B and C and Other Sexually Transmitted Infections

Est. Cumulative
Initiations:

Total PrEP: 40,000

Oral PrEP: 40,000

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Where To Access PrEP in Germany:

HIV Care Now

PrEP Jetzt

Featured Resources

Document

Rapid Assessment on Access to PrEP in EU/EEA Countries, 2022

This report clarifies the barriers to PrEP access in the EU/EEA countries, how they compare regionally, and what possible changes these countries can make to continue the fight against HIV.
Document

Ending the HIV Epidemic Germany, 2019

An assessment of HIV policy in Germany and recommendations to improve the lives of those living with, and at risk of, HIV.
Document

Rapid Assessment on Access to PrEP in EU/EEA Countries

This report by AIDS Action Europe summarizes the results of a survey of member organizations and partners based in EU Member States on various aspects of availability, accessibility, affordability, and acceptability of PrEP in their national context. In addition to the main findings, it includes country profiles and recommendations for the European Union and its…
Document

HIV PrEP in the EU/EEA and the UK: Implementation, Standards & Monitoring, 2021

This guidance was developed to support EU/EEA countries in their efforts to curb the HIV epidemic and to harmonise the overall approach to PrEP implementation in the region. It has been developed through evidence synthesis, online stakeholder consultation with experts with community, clinical and/or public health or policy- making expertise and through ongoing engagement and…
View All Resources